Valneva SE (VALN) Gross Profit (2021 - 2026)
Valneva SE (VALN) posted quarterly Gross Profit of $5.4 million for Q1 2026, down 81.96% year-on-year from $29.8 million in Q1 2025, and up 94.48% on a QoQ basis from $2.8 million in Q4 2025.
Valneva SE (VALN) Gross Profit (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Gross Profit for 6 consecutive years, with $5.4 million the latest figure, recorded in Q1 2026.
- Quarterly Gross Profit fell 81.96% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.3 million (down 63.54% YoY) and the FY2025 annual result came in at $57.8 million, down 21.62% from the prior year.
- Gross Profit improved to $5.4 million in Q1 2026 per VALN's latest filing, from $2.8 million in the prior quarter.
- Over the last five years, Gross Profit for VALN reached as high as $142.7 million in Q3 2022 and fell as low as -$98.1 million in Q2 2022.
- A 5-year average of $14.1 million and a median of $14.8 million in 2023 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit slumped 2173.62% — and 2023, when it jumped 253.52%.
- Year by year, Gross Profit stood at -$11.7 million in 2022, then soared by 253.52% to $18.0 million in 2023, then jumped by 48.84% to $26.8 million in 2024, then tumbled by 89.69% to $2.8 million in 2025, then surged by 94.48% to $5.4 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $5.4 million, $2.8 million, and -$2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.38 Mn |
| Mar 31, 2026 | 5.38 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Sep 30, 2025 | -2.35 Mn |
| Jun 30, 2025 | 27.55 Mn |
| Jun 30, 2025 | 27.55 Mn |
| Mar 31, 2025 | 29.80 Mn |
| Mar 31, 2025 | 29.80 Mn |
| Dec 31, 2024 | 26.82 Mn |
| Dec 31, 2024 | 26.82 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Jun 30, 2024 | 16.61 Mn |
| Jun 30, 2024 | 16.61 Mn |
| Mar 31, 2024 | 12.05 Mn |
| Mar 31, 2024 | 12.05 Mn |
| Dec 31, 2023 | 18.02 Mn |
| Dec 31, 2023 | 18.02 Mn |